Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Coexistence and Prognostic Significance of EVI1 Expression and Driver Mutations in KMT2A -Rearranged Acute Myeloid Leukemia

Hidemasa Matsuo, PhD, Kenichi Yoshida, MD PhD, Kana Nakatani, Yasuhiko Kamikubo, MD, PhD, Daisuke Tomizawa, MD PhD, Takashi Taga, MD PhD, Nobutaka Kiyokawa, MD PhD, Seishi Ogawa, MD PhD, Manja Meggendorfer, PhD, Claudia Haferlach, MD, Souichi Adachi, MD PhD

Blood (2019) 134 (Supplement_1): 1409.

https://doi.org/10.1182/blood-2019-124652

Published: 2019

Journal Articles

Therapeutic Targeting of RUNX-NFATC2 Axis for Acute Promyelocytic Leukemia and T Cell Immunity

Hirohito Kubota, MD, Kana Furuichi, Tatsuya Masuda, Toshiya Tatsuta, Hidefumi Hiramatsu, MD PhD, Junko Takita, MD PhD, Sugiyama Hiroshi, PhD, Souichi Adachi, MD PhD, Yasuhiko Kamikubo, MD, PhD

Blood (2019) 134 (Supplement_1): 3359.

https://doi.org/10.1182/blood-2019-126428

Published: 2019

Journal Articles

Recurrent Genomic Aberrations of D-Type Cyclins Are Therapeutic Targets of CDK4/6 Inhibitors in t(8;21) and MLL -Rearranged Acute Myeloid Leukemia

Blood (2018) 132 (Supplement 1): 2797.

https://doi.org/10.1182/blood-2018-99-111073

Published: 2018

Journal Articles

Cell-Autonomous Feedback Loop of RUNX1-p53-CBFB in Acute Myeloid Leukemia Cells

Mina Noura, Ken Morita, MD, PhD, Chieko Tokushige, Shintaro Maeda, Hiroki Kiyose, Toshikazu Bando, PhD, Kenichi Yoshida, MD PhD, Hidemasa Matsuo, Seishi Ogawa, MD PhD, Paul P. Liu, MD, PhD, Hiroshi Sugiyama, PhD, Yasuhiko Kamikubo, MD, PhD, Souichi Adachi, MD PhD

Blood (2017) 130 (Supplement 1): 1232.

https://doi.org/10.1182/blood.V130.Suppl_1.1232.1232

Published: 2017

Journal Articles

RUNX1 Enhances Leukemia Cell Engraftment in the Vascular Niche through up-Regulating E-Selectin

Chieko Tokushige, Ken Morita, MD, PhD, Shintaro Maeda, Hiroki Kiyose, Mina Noura, Tatsuki Kataoka, MD, PhD, Toshikazu Bando, PhD, Hiroshi Sugiyama, PhD, Yasuhiko Kamikubo, MD, PhD, Souichi Adachi, MD PhD

Blood (2017) 130 (Supplement 1): 1225.

https://doi.org/10.1182/blood.V130.Suppl_1.1225.1225

Published: 2017

Journal Articles

Deciphering the Function of KLF4 as a Differentiation Inducer in Hematologic Malignancies

Hiroki Kiyose, Ken Morita, MD, PhD, Shintaro Maeda, Kensho Suzuki, Souichi Adachi, MD, PhD, Yasuhiko Kamikubo, MD, PhD

Blood (2016) 128 (22): 1546.

https://doi.org/10.1182/blood.V128.22.1546.1546

Published: 2016

Journal Articles

Paradoxical Enhancement of Leukemogenesis in Acute Myeloid Leukemia Cells with Moderately Attenuated RUNX1 Expressions

Kensho Suzuki, Ken Morita, MD, PhD, Shintaro Maeda, Hiroki Kiyose, Souichi Adachi, MD, PhD, Yasuhiko Kamikubo, MD, PhD

Blood (2016) 128 (22): 2710.

https://doi.org/10.1182/blood.V128.22.2710.2710

Published: 2016

Journal Articles

Cluster Regulation of RUNX Family By "Gene Switch" Triggers a Profound Tumor Regression of Diverse Origins

Ken Morita, MD, PhD, Kensho Suzuki, Shintaro Maeda, Yoshihide Mitsuda, Ayaka Yano, Yoshimi Yamada, Hiroki Kiyose, Chieko Tokushige, Paul P. Liu, MD PhD, Souichi Adachi, MD, PhD, Hiroshi Sugiyama, PhD, Yasuhiko Kamikubo, MD, PhD

Blood (2016) 128 (22): 443.

https://doi.org/10.1182/blood.V128.22.443.443

Published: 2016

Journal Articles

Targeting Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia with a Novel Transcriptional Inhibitor

Shintaro Maeda, Ken Morita, MD, PhD, Kensho Suzuki, Hiroshi Sugiyama, PhD, Souichi Adachi, MD, PhD, Yasuhiko Kamikubo, MD, PhD

Blood (2016) 128 (22): 2737.

https://doi.org/10.1182/blood.V128.22.2737.2737

Published: 2016

Journal Articles

Prognostic Significance of CXCR4 Overexpression in Pediatric Acute Myeloid Leukemia with Low-Risk: A Report from the Japanese Pediatric Leukemia/Lymphoma Study Group

Hidemasa Matsuo, MS, Naomi Nakamura, MS, Daisuke Tomizawa, MD PhD, Akiko M. Saito, Nobutaka Kiyokawa, MDPhD, Keizo Horibe, MD PhD, Yoko Nishinaka-Arai, PhD, Mayu Tokumasu, MD, Hiroshi Itoh, MS, Yasuhiko Kamikubo, MD PhD, Hideki Nakayama, MD PhD, Akitoshi Kinoshita, MD PhD, Takashi Taga, MD PhD, Akio Tawa, MD PhD, Tomohiko Taki, MD PhD, Shiro Tanaka, PhD, Souichi Adachi, MD PhD

Blood (2015) 126 (23): 3814.

https://doi.org/10.1182/blood.V126.23.3814.3814

Published: 2015

Journal Articles

C-KIT with D816Y/V Mutations Cooperate with CBFB-MYH11 to Accelerate Leukemogenesis in Mice.

Ling Zhao, J. Joseph Melenhorst, Ph.D., Lemlem Alemu, Martha Kirby, Stacie M Anderson, Shelley Hoogstraten-Miller, Yasuhiko Kamikubo, MD, PhD, D. Gary Gilliland, MD, PhD, Pu Paul Liu

Blood (2009) 114 (22): 274.

https://doi.org/10.1182/blood.V114.22.274.274

Published: 2009

Journal Articles

Cbfb-MYH11 Can Block Hematopoiesis and Alter Gene Expression through Mechanisms Independent of Cbfb and Runx1 Repression

R. Katherine Hyde, PhD, Yasuhiko Kamikubo, MD, PhD, Lemlem Alemu, Ling Zhao, MD, PhD, Chenwei Wang, Pu Paul Liu, MD, PhD

Blood (2008) 112 (11): 747.

https://doi.org/10.1182/blood.V112.11.747.747

Published: 2008

Journal Articles

The C-Terminus of the CBFβ-SMMHC Fusion Protein Is Required for the Myeloblastic Transformation of inv16 Leukemia

Yasuhiko Kamikubo, MD, PhD, Lisa Garrett-Beal, Martha Kirby, Pu Paul Liu

Blood (2008) 112 (11): 3799.

https://doi.org/10.1182/blood.V112.11.3799.3799

Published: 2008

Journal Articles

Leukemogenesis by Truncated CBFβ-SMMHC Defective in Repressing RUNX1.

Yasuhiko Kamikubo, MD, PhD, Lisa Garrett-Beal, MS, Pu Paul Liu, M.D., Ph.D

Blood (2007) 110 (11): 462.

https://doi.org/10.1182/blood.V110.11.462.462

Published: 2007

NARROW

Coexistence and Prognostic Significance of EVI1 Expression and Driver Mutations in KMT2A -Rearranged Acute Myeloid Leukemia

Therapeutic Targeting of RUNX-NFATC2 Axis for Acute Promyelocytic Leukemia and T Cell Immunity

Recurrent Genomic Aberrations of D-Type Cyclins Are Therapeutic Targets of CDK4/6 Inhibitors in t(8;21) and MLL -Rearranged Acute Myeloid Leukemia

Cell-Autonomous Feedback Loop of RUNX1-p53-CBFB in Acute Myeloid Leukemia Cells

RUNX1 Enhances Leukemia Cell Engraftment in the Vascular Niche through up-Regulating E-Selectin

Deciphering the Function of KLF4 as a Differentiation Inducer in Hematologic Malignancies

Paradoxical Enhancement of Leukemogenesis in Acute Myeloid Leukemia Cells with Moderately Attenuated RUNX1 Expressions

Cluster Regulation of RUNX Family By "Gene Switch" Triggers a Profound Tumor Regression of Diverse Origins

Targeting Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia with a Novel Transcriptional Inhibitor

Prognostic Significance of CXCR4 Overexpression in Pediatric Acute Myeloid Leukemia with Low-Risk: A Report from the Japanese Pediatric Leukemia/Lymphoma Study Group

C-KIT with D816Y/V Mutations Cooperate with CBFB-MYH11 to Accelerate Leukemogenesis in Mice.

Cbfb-MYH11 Can Block Hematopoiesis and Alter Gene Expression through Mechanisms Independent of Cbfb and Runx1 Repression

The C-Terminus of the CBFβ-SMMHC Fusion Protein Is Required for the Myeloblastic Transformation of inv16 Leukemia

Leukemogenesis by Truncated CBFβ-SMMHC Defective in Repressing RUNX1.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only